Replies to post #18513 on Biotech Values

[io_io]

CEGE:

"The one-year survival was 88% and the two-year survival was 76%, with a mean follow-up of approximately 24 months. "

I know it's only a Phase II, but that's pretty good stuff for Pancreatic Cancer - I think median survival is among the shortest of all cancers.

[randychub]

gvax - Didn't they have good results in pancreatic cancer years ago? If so what slowed them down?

R